Keytruda
- خرداد- 1397 -26 خرداد
Merck’s Keytruda boosts response in hard-to-treat lung cancer
Merck’s Keytruda boosts response in hard-to-treat lung cancer REUTERS: The combination of Merck & Co’s immunotherapy Keytruda and chemotherapy boosted response rates in patients with…
-- بیشتر بخوانید -- - اسفند- 1396 -1 اسفنددیگر
Merck inks $394M takeover of oncolytic virus play Viralytics
Merck is set to pay $394 million to acquire Viralytics. The takeover will give Merck control of an oncolytic immunotherapy that Viralytics is testing in combination with…
-- بیشتر بخوانید -- - آذر- 1396 -3 آذردیگر
Illumina’s Jay Flatley: In “Shock and Awe” at State of Personalized Medicine
Illumina executive chairman Jay Flatley was honored with the Lifetime Achievement Award at the annual Personalized Medicine Conference on November 15, 2017, in Boston, MA.…
-- بیشتر بخوانید --
